Life sciences news
-
reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration
Wednesday August 31st 2022
Read more
-
Autoimmune disorders increase risk of cardiovascular disease
Saturday August 27th 2022
Read more
-
Biocartis obtains ISO 27001 certification for information security management
Thursday August 25th 2022
Read more
-
Alexandra Clyde appointed to Sequana Medical Board of Directors
Thursday August 25th 2022
Read more
-
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform
Thursday August 25th 2022
Read more
-
mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers investing in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA
Tuesday August 23rd 2022
Read more
-
argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis
Thursday August 11th 2022
Read more
-
Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic
Wednesday August 10th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®
Monday August 8th 2022
Read more
-
S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities
Tuesday August 2nd 2022
Read more
-
Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial
Monday August 1st 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
